KOVERA LABS · CLIENT RECORD·SNAPSHOT 2026-08-02
SYNBIOTIX (discountpeptides.co): 25 Kovera certificates.
The lab's record shows 25 certificates printed for SYNBIOTIX (discountpeptides.co), analysed between 14 Mar 2026 and 11 May 2026, covering 20 products. Median HPLC purity is 99.95%. Kovera graded 25 as a pass and 0 as a fail.
25
certificates
99.95%
median purity
20
products
0
lab verdict: fail
0
failure rules met
What the record shows
RETRIEVED 2 AUGUST 2026None of the 25 certificates meets our failure rules: no lab fail, no unconfirmed identity, no purity under 95% and no content under 90% of the label. 18 measured more than 110% of the label, which Kovera does not grade as a fail.
A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.
Products tested
20 AS PRINTEDRetatrutide · 3GHK-Cu · 2Tesamorelin · 2Tirzepatide · 2BPC-157 · 1BPC-157/TB-500 · 1Cagrilintide · 1CJC-1295 (No DAC)/Ipamorelin · 1Epithalon · 1Glow · 1Glutathione · 1IGF-1 LR3 · 1Ipamorelin · 1Klow · 1KPV · 1MOTS-c · 1Selank · 1Semaglutide · 1Semax · 1TB-500 (Thymosin B4) · 1
Every certificate
NEWEST FIRST · 25 ROWS| Report | Product | Lot | Purity | % of label | Analysed | Result | Check |
|---|---|---|---|---|---|---|---|
| KVR-2026-C518F1 | Epithalon | SYN-EPI10-001 | 99.957% | 115.4%11.54 of 10 mg | 11 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-E5D35E | Klow | SYN-KLW80-001 | 99.813% | 108.5%86.78 of 80 mg | 10 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-5622E9 | MOTS-c | SYN-MOT10-001 | 99.904% | 110.6%11.06 of 10 mg | 10 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-C4410A | Glutathione | SYN-GLT1200-001 | 99.864% | 98.7%1184.29 of 1200 mg | 1 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-E54D02 | Cagrilintide | SYN-CGL5-001 | 99.942% | 120.6%6.03 of 5 mg | 15 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-DEE155 | Ipamorelin | SYN-IPA10-001 | 99.947% | 118.9%11.89 of 10 mg | 15 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-D6C3B9 | Tirzepatide | SYN-TRZ30-001 | 99.968% | 115.1%34.52 of 30 mg | 15 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-C550F7 | Semaglutide | SYN-SM10-001 | 99.933% | 111.6%11.16 of 10 mg | 15 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-BA5E4E | IGF-1 LR3 | SYN-IGF1-001 | 99.971% | 116.0%1.16 of 1 mg | 15 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-B5C765 | Tesamorelin | SYN-TSM20-001 | 99.928% | 108.0%21.59 of 20 mg | 15 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-AD4F90 | Tesamorelin | SYN-TSM10-001 | 99.947% | 118.1%11.81 of 10 mg | 15 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-AC847C | Glow | SYN-GLW70-001 | 99.844% | 113.2%79.27 of 70 mg | 15 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-9F73A5 | BPC-157 | SYN-BPC10-001 | 99.982% | 110.9%11.09 of 10 mg | 15 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-9F3CCB | GHK-Cu | SYN-GHK100-001 | 99.954% | 115.9%115.87 of 100 mg | 15 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-8A68A1 | KPV | SYN-KPV10-001 | 99.944% | 117.8%11.78 of 10 mg | 15 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-83ED94 | BPC-157/TB-500 | SYN-WLVR10-001 | 99.687% | 109.9%10.99 of 10 mg | 15 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-602083 | GHK-Cu | SYN-GHK50-001 | 99.976% | 112.6%56.31 of 50 mg | 15 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-558DFA | Semax | SYN-SMX10-001 | 99.974% | 109.2%10.92 of 10 mg | 15 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-3054C6 | CJC-1295 (No DAC)/Ipamorelin | SYN-CJIP10-001 | 99.786% | 107.8%10.78 of 10 mg | 15 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-29291E | Selank | SYN-SNK10-001 | 99.946% | 111.9%11.19 of 10 mg | 15 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-045C8C | TB-500 (Thymosin B4) | SYN-TB10-001 | 99.967% | 112.8%11.28 of 10 mg | 15 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-F63651 | Tirzepatide | SYN-TRZ10-001 | 99.968% | 109.1%10.91 of 10 mg | 14 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-A3C9C6 | Retatrutide | SYN-RT30-001 | 99.969% | 110.6%33.18 of 30 mg | 14 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-1DD5B0 | Retatrutide | SYN-RT10-001 | 99.922% | 119.7%11.97 of 10 mg | 14 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-04A8C7 | Retatrutide | SYN-RT20-001 | 99.939% | 120.2%24.04 of 20 mg | 14 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |